Shenzhen Salubris Pharmaceuticals Co., Ltd.
尊龙凯时-人生就是搏!
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
Learn latest news of our company
follow developments of our company
News & Trends
14
2023-12
Salubris' innovative drugs Allisartan and Ena...
10
2023-10
New overseas clinical progress of JK07 for the tre...
08
2023-10
SAL0120 tablets for treatment of IgA nephropathy a...
10
2023-08
Vena cava filter system (SaExten®) approved by NMP...
09
2023-06
Enarodustat(恩那罗®) Approved by NMPA for Treatmen...
Learn more News & Trends